Beneficient (NASDAQ:BENF – Get Free Report) was the target of a significant decline in short interest in the month of October. As of October 15th, there was short interest totaling 516,945 shares, a decline of 45.6% from the September 30th total of 950,383 shares. Currently, 12.8% of the shares of the company are short sold. Based on an average daily volume of 1,150,374 shares, the short-interest ratio is currently 0.4 days.
Institutional Inflows and Outflows
An institutional investor recently bought a new stake in Beneficient stock. T3 Companies LLC purchased a new stake in Beneficient (NASDAQ:BENF – Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 43,030 shares of the company’s stock, valued at approximately $59,000. T3 Companies LLC owned 0.28% of Beneficient at the end of the most recent reporting period. 90.57% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
Several equities analysts recently issued reports on the company. Weiss Ratings reiterated a “sell (e+)” rating on shares of Beneficient in a report on Monday, September 21st. Wall Street Zen upgraded shares of Beneficient to a “hold” rating in a research note on Saturday, October 24th. One analyst has rated the stock with a Sell rating. According to data from MarketBeat, the stock currently has an average rating of “Sell”.
View Our Latest Stock Analysis on BENF
Beneficient Price Performance
Shares of NASDAQ BENF traded down $0.07 during mid-day trading on Friday, hitting $0.73. 266,591 shares of the stock traded hands, compared to its average volume of 643,123. Beneficient has a twelve month low of $0.50 and a twelve month high of $9.96. The company has a market cap of $11.35 million, a PE ratio of -0.10 and a beta of -0.01. The firm has a 50 day simple moving average of $1.33 and a two-hundred day simple moving average of $3.05.
Beneficient (NASDAQ:BENF – Get Free Report) last released its quarterly earnings results on Friday, August 14th. The company reported ($0.47) EPS for the quarter, beating analysts’ consensus estimates of ($2.06) by $1.59. The company had revenue of $15.93 million during the quarter, compared to the consensus estimate of $10.16 million. On average, equities research analysts anticipate that Beneficient will post -9.50 earnings per share for the current fiscal year.
Beneficient Company Profile
Beneficient (NASDAQ: BENF) is a financial services company that provides liquidity and trust solutions for holders of alternative assets. Its platform is designed to help investors access liquidity from interests in private equity, venture capital, private credit, real estate and other illiquid investments without relying solely on traditional secondary-market sales.
The company’s offerings include the ExAlt Plan, which is structured to allow eligible investors to contribute alternative assets to trusts in exchange for interests that may provide access to liquidity, and AltQuote, a technology-enabled service intended to help investors evaluate potential liquidity options for their holdings.
See Also
- Five stocks we like better than Beneficient
- Marvell Eyes a Swing for the AI Networking Fences as Markets Weigh Lumentum Price Tag
- Exxon’s Refining Profits Soared—Did Chevron Get the Same Windfall?
- Eli Lilly’s First Full Medicare Quarter: Is Volume Still Outrunning Price Cuts?
- Oracle’s AI Spending Peak Is in Sight—Can the Stock Recover?
Receive News & Ratings for Beneficient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beneficient and related companies with MarketBeat.com's FREE daily email newsletter.
